Why Am I Not Losing Weight on Wegovy or Another GLP-1?

You started a GLP-1 expecting the weight to come off, and for a while it might have. Now the scale won't move, or it never really did. The appetite is quieter, the food noise is gone, and yet the number is stuck. It's one of the most common and most demoralizing parts of treatment, and almost always it has a concrete, fixable cause rather than some failure on your part.

A stall on Wegovy, Mounjaro, Zepbound, or compounded semaglutide usually comes down to timing, dose, or what's happening around the medication, not the drug giving up. Below are the reasons the scale stops moving, what the clinical trials actually showed about the pace of loss, and how to tell which one is yours.

It may not have been long enough

The biggest reason people think a GLP-1 isn't working is that they're measuring against a timeline the drug was never going to hit. The headline results take a long time to build. In the STEP 1 trial of semaglutide, the mean body-weight reduction was about 15% — but that was at 68 weeks, more than a year of treatment. Tirzepatide's SURMOUNT-1 trial reached roughly 21% at the top dose, measured at 72 weeks. The loss in those studies was steady and slow, not a fast early drop that then continues.

Appetite suppression also shows up well before the scale does. You can feel full on half your usual plate within days of a dose change and still see nothing on the scale for weeks, because water shifts, glycogen, and digestion mask the early fat loss. If you want the honest version of the curve, we walk through it in detail in how long does it take for semaglutide to suppress appetite. Four weeks in with a stuck scale is normal. Four months in at a low dose with no change is a different conversation.

You're not at your effective dose yet

GLP-1 medications are deliberately started low and raised slowly, and the starting doses are not really weight-loss doses. They exist to let your gut adjust so the nausea is tolerable. Wegovy, for example, climbs over roughly 16 to 20 weeks before it reaches the 2.4 mg maintenance dose that the trials were built on, a schedule set out in its FDA prescribing information. Spend two months on 0.25 mg or 0.5 mg of semaglutide and a flat scale isn't the drug failing, it's the drug not having started in earnest.

This is where a lot of stalls quietly resolve. People pause at a mid-tier dose because the appetite suppression feels like enough, or because a prescriber held them there to manage side effects, and then they wonder why progress flattened. The titration schedule is itself the treatment plan — the units matter, and the jump from one step to the next is often what restarts the loss. We lay the full ladder out in the tirzepatide dosing for weight loss in units guide. Whether you should move up is a question for your prescriber, not a decision to make alone, but knowing where you sit on the curve tells you whether a plateau is real or just premature.

You've hit a real plateau

Sometimes the stall is genuine, and it's biology doing exactly what it evolved to do. As you lose weight, your body burns fewer calories at rest, partly because there's less of you to power and partly through adaptive thermogenesis, a measurable drop in metabolic rate beyond what size alone predicts. Researchers tracked this for years in a well-known study of metabolic adaptation and found the slowdown can persist long after the weight comes off. Your hunger hormones push the other way at the same time, defending a higher set point.

A GLP-1 counters that defense, which is why it works where willpower alone stalls, but it doesn't switch the defense off. Most people reach a new equilibrium where intake and a lower metabolic rate balance out, and the scale settles. That's also why stopping the medication so often reverses things — the same set-point biology that causes a plateau drives the regain we cover in weight regain after stopping semaglutide. A true plateau after meaningful loss isn't failure. It's the point where the next move is a dose review or a change in what surrounds the medication, not panic.

The scale is hiding what changed

The bathroom scale measures one number and throws away everything useful about it. Fat, muscle, water, and the contents of your gut all read the same. A week where you drop two pounds of fat and gain a pound of water from a hard workout or a salty meal looks like a one-pound loss, or like nothing. Over a stretch of training, recomposition can flatten the scale entirely while your waistband keeps loosening.

This matters more on a GLP-1 than people expect, because rapid loss carries a real risk of shedding lean mass along with fat. If you're not protecting muscle, you can lose weight that you'll wish you'd kept and still feel cheated by a stubborn number. The fix is to stop trusting the scale alone. Track waist circumference, how clothes fit, progress photos every few weeks, and strength in the gym. If those are all moving and the scale isn't, you're not stalled, you're just reading the wrong instrument.

Calories crept back in

GLP-1s work by making it easier to eat less, not by making calories not count. The deficit still has to exist. Early on, the appetite suppression is so strong that the deficit happens on its own — you forget to finish meals, snacking loses its pull, and the weight moves. As your body adapts and the initial novelty of the dose fades, that effortless deficit can narrow without you noticing.

People also learn to eat around the medication. Liquid calories slip past appetite suppression almost untouched, so a daily latte, juice, or alcohol can quietly erase the deficit a smaller plate created. Calorie-dense soft foods go down easily even when solid meals feel like too much. None of this means you're doing it wrong, but if the scale stalled around the same time your dose stopped feeling dramatic, a few days of honest food logging usually finds the gap. The goal isn't to white-knuckle it, it's to see where the easy calories returned.

Protein, sleep, and stress

When appetite drops hard, the foods that get crowded out first tend to be the ones that take effort to eat, and protein is usually the casualty. Too little protein both costs you muscle and leaves you hungrier between meals, which works against the medication. Most clinicians point people toward a protein target in the range of 0.6 to 0.8 grams per pound of goal body weight a day, paired with resistance training, to hold onto lean mass while the fat comes off. Hitting that on a suppressed appetite takes planning — protein first at every meal, often before anything else.

Sleep and stress are the quiet levers. Short sleep raises hunger signaling and pushes you toward exactly the easy, calorie-dense foods a GLP-1 was helping you skip. Chronic stress keeps cortisol elevated, which encourages fat storage around the middle and disrupts the same appetite hormones the drug is trying to steady. None of these undo the medication, but stack a few of them together and they can fully cancel out a stall's worth of progress. Fixing sleep and protein is unglamorous, and it's often what breaks a plateau when a dose change isn't on the table yet.

Something medical, or the product itself

A handful of medical situations can blunt weight loss no matter how well the GLP-1 is dosed. An underactive thyroid slows metabolism. Polycystic ovary syndrome and insulin resistance change how the body handles weight, which is part of why GLP-1s are studied specifically in that population — we go deeper on that in glp-1 fertility pcos. Some common medications, including certain antidepressants, antipsychotics, beta-blockers, and steroids, are associated with weight gain or resistance to loss. If your scale never budged from the start despite a real dose and a real deficit, this is worth raising with your prescriber rather than assuming the drug is the problem.

Then there's the product itself. The compounded semaglutide and tirzepatide market exploded during the brand shortages, and quality varies enormously. An underdosed, mishandled, or counterfeit vial can produce mild appetite suppression with little weight loss, which feels exactly like a plateau. If you're using a compounded product and getting a fraction of the expected effect, the medication may simply not contain what the label claims — a risk we break down in are skinny shots safe. Sourcing from a verified provider and pharmacy is the only real safeguard. Understanding what the molecule is supposed to do in the first place, which we cover in how does ozempic work, makes it a lot easier to spot when something is off.

How long should it take to start losing weight on a GLP-1?

Most people notice appetite suppression within the first week or two of a dose, but visible scale movement is slower and less linear. In the major trials, the loss accumulated steadily over many months — about 15% of body weight at 68 weeks for semaglutide in STEP 1 and roughly 21% at 72 weeks for tirzepatide in SURMOUNT-1. Early weeks at a starting dose are mostly about your gut adjusting, not maximum weight loss. A flat scale in the first month, especially before you've reached a maintenance dose, is common and usually not a sign the medication isn't working.

Is it normal to stall on Wegovy or Mounjaro?

Yes. Plateaus are an expected part of weight loss, not a malfunction. As you lose weight your body burns fewer calories at rest and your hunger signaling pushes back, so intake and a lower metabolic rate eventually balance out and the scale settles. On a GLP-1 this often coincides with reaching a maintenance dose. A short stall of a week or two means little. A stall lasting many weeks at a stable dose is the point to review your protein, sleep, calorie intake, and whether a dose adjustment is appropriate with your prescriber.

Should I increase my dose if I'm not losing weight?

A dose increase is a decision for your prescriber, not something to do on your own or by stretching a compounded vial. That said, moving up the titration ladder is one of the most common ways a stall gets unstuck, because the starting and mid-tier doses are not the full weight-loss doses studied in trials. Before raising the dose, a good clinician will usually check that the basics are in place — adequate protein, a genuine calorie deficit, and enough time at the current dose. If those are covered and progress has truly flattened, the next titration step is often the right next move.

Can compounded semaglutide be the reason it's not working?

It can. Compounded semaglutide and tirzepatide are not FDA-approved products, and their potency, purity, and dosing accuracy vary by the pharmacy that makes them. An underdosed or mishandled vial can produce just enough appetite suppression to feel like the medication is doing something while delivering little actual weight loss, which mimics a plateau. If you're on a compounded product and getting a fraction of the expected effect, that's a reason to question the source. Using a verified provider and a reputable pharmacy is the best protection against paying for a product that doesn't contain what it claims.